Department of Hemodialysis and Apheresis, The University of Tokyo Hospital, Tokyo, Japan.
Department of Health Economics and Epidemiology Research, School of Public Health, The University of Tokyo, Tokyo, Japan.
Nephrol Dial Transplant. 2015 Jun;30(6):988-95. doi: 10.1093/ndt/gfv069. Epub 2015 Mar 19.
Nationwide data for the prevalence and outcomes of patients receiving continuous renal replacement therapy (CRRT) in intensive care units (ICUs) are scarce. This study assessed the status of CRRT in Japanese ICUs using a nationwide administrative claim database.
Data were extracted from the Japanese Diagnosis Procedure Combination database for 2011. From a cohort of critically ill patients aged 12 years or older who were admitted to ICUs for 3 days or longer, acute kidney injury (AKI) patients treated with CRRT were identified. The period prevalence of CRRT and in-hospital mortality were calculated. Logistic regression analysis identified factors associated with in-hospital mortality.
Of 165 815 ICU patients, 6478 (3.9%) received CRRT for AKI. The most frequent admission diagnosis category was diseases of the circulatory system (n = 3074). The overall in-hospital mortality rate of the CRRT-treated AKI patients was 50.6%. Clustering patients into four groups by background revealed the lowest in-hospital mortality rate of 41.5% for the cardiovascular surgery group (n = 1043) compared with 53.5% for the nonsurgical cardiovascular group (n = 2031), 51.7% for the sepsis group (n = 1863) and 51.6% for other cases (n = 1541). Multiple logistic regression analysis showed a significant association of these four group classifications with in-hospital mortality in addition to age, hospital characteristics (type and volume), time from hospital admission to CRRT initiation and interventions performed on the day of CRRT initiation.
Using a large Japanese nationwide database, this study revealed remarkably high in-hospital mortality of CRRT-treated AKI patients, although the period prevalence of CRRT for AKI in ICUs was low.
关于重症监护病房(ICU)中接受连续肾脏替代治疗(CRRT)的患者的患病率和结局的全国性数据很少。本研究使用全国性行政索赔数据库评估日本 ICU 中 CRRT 的现状。
从 2011 年日本诊断程序组合数据库中提取数据。从入住 ICU 3 天或更长时间的年龄在 12 岁及以上的危重病患者队列中,确定接受 CRRT 治疗的急性肾损伤(AKI)患者。计算 CRRT 的期间患病率和院内死亡率。使用逻辑回归分析确定与院内死亡率相关的因素。
在 165815 名 ICU 患者中,有 6478 名(3.9%)因 AKI 接受 CRRT 治疗。最常见的入院诊断类别是循环系统疾病(n=3074)。接受 CRRT 治疗的 AKI 患者的总体院内死亡率为 50.6%。根据背景将患者分为四组,心血管手术组(n=1043)的院内死亡率最低,为 41.5%,而非手术心血管组(n=2031)为 53.5%,脓毒症组(n=1863)为 51.7%,其他病例(n=1541)为 51.6%。多变量逻辑回归分析显示,除年龄、医院特征(类型和容量)、从入院到开始 CRRT 的时间以及开始 CRRT 当天进行的干预外,这四个分组与院内死亡率显著相关。
使用大型日本全国性数据库,本研究显示 ICU 中接受 CRRT 治疗的 AKI 患者的院内死亡率非常高,尽管 ICU 中 AKI 的 CRRT 期间患病率较低。